Trial Profile
Multi-country study of Drug utilization in real world use of dulaglutide in Europe
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2018
Price :
$35
*
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 21 Sep 2018 New trial record
- 26 Aug 2018 Results of drug utilization patterns were presented at the 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management